Efficacy of Bilastine Up-dosing (40 mg ) Versus Combination of Bilastine (20 mg )With Levocitirizine (5 mg) in the Treatment of Chronic Spontaneous Urticaria

Clinical trial NCT07365683 · COMPLETED

Trial details

NCT number: NCT07365683
Sponsor: Derma Techno Pakistan
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Chronic Spontaneous Urticaria (CSU)

Start date: 2025-08-18
Primary completion: 2026-01-10
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.